PolarisQB is utilizing Quantum Computing, Artificial Intelligence, Machine Learning and Personalized Medicine to Revolutionize Drug Design. By compressing the lead time for pre-clinical drug candidates from 5 years to 4 months, we will produce up to 100 drug blueprints per year, enabling real time adaptability within the precision medicine market. Using these methodologies, Polaris will build an IP portfolio of drug assets to license, sell, or develop internally.
| Website | http://www.polarisqb.com |
| Employees | 10 (10 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research, Drug Discovery, Discovery Tools (Healthcare) |
| Keywords | Drug Design, Quantum Computing, Preclinical Drug Development, Drug Discovery, Computational Drug Discovery, Artificial Intelligence, Machine Learning, Therapeutic Discovery, Personalized Medicine, Pharmaceutical Research, Ai In Healthcare, Precision Medicine, Pharmaceutical Innovation, Biotechnology, Molecular Modeling, Life Sciences, Healthcare Technology |
| Competitors | Microsoft, IBM, Honeywell, Rigetti Computing, D-Wave Systems Inc., Xanadu, QCI. More Than Technology. Understanding., Zapata Computing, Inc., Ionq Inc., AI Community +20 more (view full list) |
Looking for a particular POLARISqb employee's phone or email?
Shahar Keinan is the CEO and co-founder of POLARISqb.
10 people are employed at POLARISqb.